GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | BCL2 | decreases expression | EXP | | 6480464 | CTD | Decitabine results in decreased expression of BCL2 mRNA; Decitabine results in decreased expression of BCL2 protein | PMID:18636160 PMID:22082530 | BCL2 | increases expression | EXP | | 6480464 | CTD | Decitabine results in increased expression of BCL2 mRNA | PMID:21515334 | BCL2 | multiple interactions | EXP | | 6480464 | CTD | [Decitabine co-treated with epigallocatechin gallate] affects the expression of BCL2 mRNA; Decitabine inhibits the reaction [Estradiol affects the expression of BCL2 mRNA]; Decitabine inhibits the reaction [tetraethoxysilane analog results in increased methylation of BCL2 promoter] | PMID:18250043 PMID:22082530 PMID:27362941 | BCL2 | increases expression | ISO | Bcl2 (Mus musculus) | 6480464 | CTD | Decitabine results in increased expression of BCL2 mRNA | PMID:27915011 | BCL2 | multiple interactions | ISO | Bcl2 (Rattus norvegicus) | 6480464 | CTD | [Paraquat co-treated with Decitabine] results in decreased expression of BCL2 protein; Decitabine inhibits the reaction [Benzene results in decreased expression of BCL2 mRNA] | PMID:21143203 PMID:22796470 | |
Go Back to source page | Continue to Ontology report |